scispace - formally typeset
L

Lijuan Yang

Researcher at University of Waterloo

Publications -  8
Citations -  153

Lijuan Yang is an academic researcher from University of Waterloo. The author has contributed to research in topics: Catalysis & Wilkinson's catalyst. The author has an hindex of 5, co-authored 8 publications receiving 125 citations.

Papers
More filters
Journal ArticleDOI

Homogeneous Hydrogenation Art of Nitrile Butadiene Rubber: A Review

TL;DR: An overview of the fundamental data, challenges, and recent advances in the research area of homogeneous hydrogenation of nitrile butadiene rubber (NBR) is provided in this article.
Journal ArticleDOI

Development of a green separation technique for recovery of Wilkinson's catalysts from bulk hydrogenated nitrile butadiene rubber

TL;DR: In this paper, the performance of different CO2-expanded methanol (CXM) and CO2expanded ethanol (CXE) for the removal of Wilkinson's catalyst from HNBR with assistance of various chelating agents was evaluated.
Journal ArticleDOI

Organic solvent-free catalytic hydrogenation of diene-based polymer nanoparticles in latex form. Part II. Kinetic analysis and mechanistic study

TL;DR: In this paper, very small diene-based polymer nanoparticles were synthesized and then used as the substrates for the subsequent latex hydrogenation, and an apparent first-order kinetic model was proposed to describe the rate of hydrogen uptake with respect to the concentration of the olefinic substrate.
Journal ArticleDOI

Recovery of Wilkinson's catalyst from polymer based matrix using carbon dioxide expanded methanol

TL;DR: In this article, carbon dioxide-expanded methanol (CXM) is employed to recover Wilkinson's catalyst from the matrix of hydrogenated nitrile butadiene rubber (HNBR) using the chelating agent N,N, N′,N′, N″-pentamethyldiethylenetriamine (PMDETA).
Journal ArticleDOI

Preparation of pH-responsive polymer core-shell nanospheres for delivery of hydrophobic antineoplastic drug ellipticine.

TL;DR: The synthesis and encapsulation process developed herein provides a new perspective for the development of appropriate delivery systems to deliver the ellipticine and its analogues, as well as other types of hydrophobic drugs to a given target cell or tumor tissue.